Home

toilet Analytisch optellen daniel den hoed cancer center bekennen Split Pakket

Response to adjuvant chemotherapy in primary breast cancer: no
Response to adjuvant chemotherapy in primary breast cancer: no

Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy  for advanced breast cancer
Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancer

Stichting Daniel den Hoed - Historie
Stichting Daniel den Hoed - Historie

Today's patients
Today's patients

Heating the patient: a promising approach?
Heating the patient: a promising approach?

Maak Kanker Kansloos van start - Nieuws - Erasmus MC
Maak Kanker Kansloos van start - Nieuws - Erasmus MC

Pelvic exenteration for primary and recurrent gynaecological malignancies
Pelvic exenteration for primary and recurrent gynaecological malignancies

Clinical introduction of Monte Carlo treatment planning: A different  prescription dose for non-small cell lung cancer according
Clinical introduction of Monte Carlo treatment planning: A different prescription dose for non-small cell lung cancer according

Surveillance with Microsatellite Analysis of Urine in Bladder Cancer  PatientsTreated by Radiotherapy
Surveillance with Microsatellite Analysis of Urine in Bladder Cancer PatientsTreated by Radiotherapy

Historie - Over radioloog Daniel den Hoed | Daniel den Hoed fonds
Historie - Over radioloog Daniel den Hoed | Daniel den Hoed fonds

Glycolipids of human primary testicular germ cell tumours
Glycolipids of human primary testicular germ cell tumours

The Dutch Deep Hyperthermia Trial: results in cervical cancer
The Dutch Deep Hyperthermia Trial: results in cervical cancer

European Organization for Research and Treatment of Cancer (EORTC) open  label phase II study on glufosfamide administered as a 6
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 6

Assessment of insertion techniques and complication rates of dual lumen  central venous catheters in patients with hematological
Assessment of insertion techniques and complication rates of dual lumen central venous catheters in patients with hematological

Considerations of Healthcare Professionals in Medical Decision-Making About  Treatment for Clinical End-Stage Cancer Patients
Considerations of Healthcare Professionals in Medical Decision-Making About Treatment for Clinical End-Stage Cancer Patients

Nitrous oxide is not beneficial for breakthrough cancer pain
Nitrous oxide is not beneficial for breakthrough cancer pain

Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in  testicular germ cell tumour cell lines. - Abstract - Europe PMC
Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines. - Abstract - Europe PMC

Patiëntenzorg - Erasmus MC Kanker Instituut
Patiëntenzorg - Erasmus MC Kanker Instituut

Familiehuis Daniel den Hoed | Rotterdam
Familiehuis Daniel den Hoed | Rotterdam

Necrosis Factor-Alpha, Meiphalan, and
Necrosis Factor-Alpha, Meiphalan, and

Management of recurrent malignant pleural effusions with a chronic  indwelling pleural catheter
Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter